

Iohexol API Market Scope: Industry Analysis, Market
Size, Growth, Trends
Till 2031
Request Sample Report
The Iohexol API market research report analyzes current market conditions, trends, and growth opportunities. The market size for Iohexol API is projected to reach a value of $XX million by 2027, driven by increasing demand for contrast agents in medical imaging procedures.
Request Sample Report
◍ GE Healthcare
◍ BeiLu Pharma
◍ Fuji Pharma
◍ Stellite
◍ Haichang Pharmaceutical
The Iohexol API market is highly competitive with key players like GE Healthcare, BeiLu Pharma, Fuji Pharma, Stellite, and Haichang Pharmaceutical. These companies produce and distribute Iohexol API for use in diagnostic imaging procedures. They contribute to the growth of the market by providing high-quality products and expanding their global reach.
- GE Healthcare: $19.96 billion
- Fuji Pharma: $1.55 billion
- Haichang Pharmaceutical: $870 million Request Sample Report
By Application
◍ Hospitals
◍ Clinics
By Product
◍ Original Drug
◍ Generic Drug
Request Sample Report